Michael Schmidt
Stock Analyst at Guggenheim
(4.94)
# 163
Out of 4,651 analysts
506
Total ratings
57.6%
Success rate
31.9%
Average return
Main Sectors:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $45 | $29.51 | +52.49% | 12 | Aug 13, 2026 | |
| IMNM Immunome | Maintained: Buy | $35 | $27.20 | +28.68% | 7 | Aug 12, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $28 | $15.50 | +80.65% | 11 | Aug 12, 2026 | |
| ERAS Erasca | Maintained: Buy | $20 → $21 | $18.38 | +14.25% | 9 | Aug 12, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $45 → $52 | $37.93 | +37.09% | 7 | Aug 11, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $32 → $35 | $25.60 | +36.72% | 12 | Aug 11, 2026 | |
| CTMX CytomX Therapeutics | Maintained: Buy | $15 → $14 | $3.36 | +316.67% | 5 | Aug 7, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Maintained: Buy | $10 | $3.56 | +180.90% | 13 | Aug 7, 2026 | |
| VSTM Verastem | Maintained: Buy | $14 → $12 | $6.58 | +82.37% | 11 | Aug 6, 2026 | |
| XFOR X4 Pharmaceuticals | Maintained: Buy | $12 | $4.22 | +184.36% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $42 | $31.94 | +31.50% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 → $240 | $203.71 | +17.81% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $420 → $430 | $347.48 | +23.75% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $58 | $48.22 | +20.28% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $78 | $58.82 | +32.61% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $136 → $150 | $120.16 | +24.83% | 43 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.97 | - | 16 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $37.07 | +7.90% | 1 | Jul 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.83 | - | 4 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.01 | +890.10% | 15 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.70 | - | 7 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $38.31 | -6.03% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.26 | +91.69% | 2 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $51.24 | - | 43 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $117.39 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $2.25 | n/a | 6 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $19.86 | n/a | 5 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.029 | n/a | 15 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.22 | n/a | 9 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.98 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.37 | n/a | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $34.21 | n/a | 2 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2,027.00 | n/a | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.35 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.06 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.05 | n/a | 6 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9199 | n/a | 4 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.17 | n/a | 7 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $43 | $19.84 | n/a | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 | $8.38 | n/a | 6 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $13.87 | n/a | 3 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.57 | n/a | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.05 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $63 | $33.56 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $415.21 | n/a | 2 | Sep 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 | $23.34 | n/a | 13 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.14 | n/a | 2 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $140 → $85 | $8.83 | n/a | 5 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 | $76.83 | n/a | 1 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.86 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $48.62 | n/a | 10 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $15 | $0.93 | n/a | 5 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.67 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $0.0001 | n/a | 6 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $57.24 | n/a | 9 | Oct 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $228.65 | n/a | 12 | Oct 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $1.5 | $1.22 | n/a | 5 | Sep 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $2.02 | n/a | 8 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.91 | n/a | 3 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.41 | n/a | 3 | Aug 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $49.06 | n/a | 4 | Oct 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $181 | $244.96 | n/a | 5 | Aug 6, 2014 |
ArriVent BioPharma
Aug 13, 2026
Reiterated: Buy
Price Target: $45
Current: $29.51
Upside: +52.49%
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $35
Current: $27.20
Upside: +28.68%
Monte Rosa Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $28
Current: $15.50
Upside: +80.65%
Erasca
Aug 12, 2026
Maintained: Buy
Price Target: $20 → $21
Current: $18.38
Upside: +14.25%
Cogent Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $45 → $52
Current: $37.93
Upside: +37.09%
Tango Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $25.60
Upside: +36.72%
CytomX Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $15 → $14
Current: $3.36
Upside: +316.67%
Zentalis Pharmaceuticals
Aug 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.56
Upside: +180.90%
Verastem
Aug 6, 2026
Maintained: Buy
Price Target: $14 → $12
Current: $6.58
Upside: +82.37%
X4 Pharmaceuticals
Aug 6, 2026
Maintained: Buy
Price Target: $12
Current: $4.22
Upside: +184.36%
Aug 6, 2026
Maintained: Buy
Price Target: $40 → $42
Current: $31.94
Upside: +31.50%
Aug 6, 2026
Maintained: Buy
Price Target: $235 → $240
Current: $203.71
Upside: +17.81%
Aug 5, 2026
Maintained: Buy
Price Target: $420 → $430
Current: $347.48
Upside: +23.75%
Aug 5, 2026
Maintained: Buy
Price Target: $42 → $58
Current: $48.22
Upside: +20.28%
Aug 5, 2026
Maintained: Buy
Price Target: $80 → $78
Current: $58.82
Upside: +32.61%
Jul 28, 2026
Maintained: Buy
Price Target: $136 → $150
Current: $120.16
Upside: +24.83%
Jul 17, 2026
Rated: Hold
Price Target: n/a
Current: $8.97
Upside: -
Jul 5, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $37.07
Upside: +7.90%
Jul 1, 2026
Rated: Hold
Price Target: n/a
Current: $2.83
Upside: -
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $1.01
Upside: +890.10%
Jun 16, 2026
Maintained: Hold
Price Target: n/a
Current: $1.70
Upside: -
May 5, 2026
Reiterated: Buy
Price Target: $36
Current: $38.31
Upside: -6.03%
Mar 11, 2026
Maintained: Buy
Price Target: $12
Current: $6.26
Upside: +91.69%
Feb 10, 2026
Maintained: Hold
Price Target: n/a
Current: $51.24
Upside: -
Aug 11, 2025
Maintained: Buy
Price Target: $60
Current: $117.39
Upside: n/a
Aug 11, 2025
Maintained: Buy
Price Target: $10 → $12
Current: $2.25
Upside: n/a
Aug 7, 2025
Maintained: Buy
Price Target: $10
Current: $19.86
Upside: n/a
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.029
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $4.22
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $6.98
Upside: n/a
May 23, 2025
Rated: Hold
Price Target: n/a
Current: $20.37
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: n/a
Current: $34.21
Upside: n/a
Jun 27, 2024
Maintained: Hold
Price Target: n/a
Current: $2,027.00
Upside: n/a
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.35
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $5.06
Upside: n/a
Jan 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.05
Upside: n/a
Dec 20, 2023
Rated: Hold
Price Target: n/a
Current: $0.9199
Upside: n/a
Dec 7, 2023
Maintained: Buy
Price Target: n/a
Current: $9.17
Upside: n/a
Oct 3, 2023
Maintained: Buy
Price Target: $40 → $43
Current: $19.84
Upside: n/a
Jun 27, 2023
Downgraded: Hold
Price Target: $20
Current: $8.38
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $15
Current: $13.87
Upside: n/a
Jan 3, 2023
Downgraded: Hold
Price Target: n/a
Current: $2.57
Upside: n/a
Apr 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $3.05
Upside: n/a
Feb 25, 2021
Maintained: Buy
Price Target: $66 → $63
Current: $33.56
Upside: n/a
Sep 18, 2020
Maintained: Hold
Price Target: n/a
Current: $415.21
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $44
Current: $23.34
Upside: n/a
Jun 23, 2020
Maintained: Buy
Price Target: n/a
Current: $36.14
Upside: n/a
Sep 17, 2018
Initiated Coverage: Buy
Price Target: $140 → $85
Current: $8.83
Upside: n/a
May 8, 2017
Initiated Coverage: Hold
Price Target: $19
Current: $76.83
Upside: n/a
Nov 30, 2016
Maintained: Buy
Price Target: n/a
Current: $1.86
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $27 → $23
Current: $48.62
Upside: n/a
Nov 11, 2016
Reiterated: Hold
Price Target: $1.5 → $15
Current: $0.93
Upside: n/a
Nov 10, 2016
Reiterated: Hold
Price Target: $5
Current: $4.67
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $3 → $2
Current: $0.0001
Upside: n/a
Oct 9, 2016
Reiterated: Hold
Price Target: $36
Current: $57.24
Upside: n/a
Oct 5, 2016
Reiterated: Hold
Price Target: $40
Current: $228.65
Upside: n/a
Sep 20, 2016
Reiterated: Hold
Price Target: $4 → $1.5
Current: $1.22
Upside: n/a
Sep 6, 2016
Reiterated: Buy
Price Target: $18
Current: $2.02
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: n/a
Current: $11.91
Upside: n/a
Aug 16, 2016
Reiterated: Buy
Price Target: $28
Current: $5.41
Upside: n/a
Oct 6, 2015
Reiterated: Buy
Price Target: n/a
Current: $49.06
Upside: n/a
Aug 6, 2014
Rated: Buy
Price Target: $177 → $181
Current: $244.96
Upside: n/a